Publications

The surveillance for antineoplastic exposures (SurFACEs) study

Description

Antineoplastic drugs (AD) used in treatment of cancer can present an occupational health hazard to healthcare workers causing adverse reproductive effects and increasing their risk of cancer. This report presents the findings of a large-scale exposure assessment study which focused on wipe-sampling of hard surfaces to determine the presence and level of AD residues in six representative cancer care facilities in Alberta and three in Minneapolis, Minnesota.

Updated

April 1, 2020

Tags
OHS Futures OHS Futures Research Funding Program Occupational Health and Safety Futures Research Funding Program antineoplastic drugs health care facilities healthcare workers occupational health hazards work conditions

Title and publication information

Type
Report
Extent

54 pages

Frequency

Once

Publisher / Creator Information

Publisher

Jobs, Economy and Northern Development

Contributor

Davies, Hugh W.

Contributor

Arnold, Susan

Contributor

Astrakianakis, G.

Contributor

Jeronimo, M.

Contributor

Lyden, G.

Contributor

Steward, Q. H.

Place of Publication

Edmonton

Subject Information

Resource Dates

Date Created

2020-04-01

Date Added

2023-05-31T21:11:15.189802

Date Modified

2020-04-01

Date Issued

2023-06-07

Identifiers

Usage / Licence

Usage Considerations

Funding for this research was provided by the OHS Futures Research Funding Program. The research was not conducted by the Government of Alberta and any statements, findings or conclusions presented are not endorsed by the GoA. Requests for further information or questions about the research should be addressed to the authors of the report directly.

Licence

No licence

Contact

Contact Name

OHS Futures Research Grant Program

Contact Email

OHSFutures@gov.ab.ca